Schalkwijk, H.H.; Gillemot, S.; Frobert, E.; Morfin, F.; Ducastelle, S.; Conrad, A.; Fiten, P.; Opdenakker, G.; Snoeck, R.; Andrei, G.
Primary HSV-2 Infection in an Immunocompromised Patient Reveals High Diversity of Drug-Resistance Mutations in the Viral DNA Polymerase. Viruses 2025, 17, 962.
https://doi.org/10.3390/v17070962
AMA Style
Schalkwijk HH, Gillemot S, Frobert E, Morfin F, Ducastelle S, Conrad A, Fiten P, Opdenakker G, Snoeck R, Andrei G.
Primary HSV-2 Infection in an Immunocompromised Patient Reveals High Diversity of Drug-Resistance Mutations in the Viral DNA Polymerase. Viruses. 2025; 17(7):962.
https://doi.org/10.3390/v17070962
Chicago/Turabian Style
Schalkwijk, Hanna Helena, Sarah Gillemot, Emilie Frobert, Florence Morfin, Sophie Ducastelle, Anne Conrad, Pierre Fiten, Ghislain Opdenakker, Robert Snoeck, and Graciela Andrei.
2025. "Primary HSV-2 Infection in an Immunocompromised Patient Reveals High Diversity of Drug-Resistance Mutations in the Viral DNA Polymerase" Viruses 17, no. 7: 962.
https://doi.org/10.3390/v17070962
APA Style
Schalkwijk, H. H., Gillemot, S., Frobert, E., Morfin, F., Ducastelle, S., Conrad, A., Fiten, P., Opdenakker, G., Snoeck, R., & Andrei, G.
(2025). Primary HSV-2 Infection in an Immunocompromised Patient Reveals High Diversity of Drug-Resistance Mutations in the Viral DNA Polymerase. Viruses, 17(7), 962.
https://doi.org/10.3390/v17070962
